Daxor EBITDA 2010-2011 | DXR

Daxor ebitda from 2010 to 2011. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Daxor Annual EBITDA
(Millions of US $)
2011 $-5
2010 $-5
2009 $-5
Daxor Quarterly EBITDA
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-1
2011-06-30 $-1
2011-03-31 $-2
2010-12-31 $-1
2010-09-30 $-1
2010-06-30 $-1
2010-03-31 $-1
2009-12-31 $-1
2009-09-30 $-1
2009-06-30 $-1
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.041B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.877B 0.00
Quest Diagnostics (DGX) United States $16.876B 17.10
DaVita (DVA) United States $13.632B 17.63
Encompass Health (EHC) United States $9.545B 22.50
Chemed (CHE) United States $8.349B 25.66
Elanco Animal Health (ELAN) United States $5.942B 14.14
Option Care Health (OPCH) United States $4.962B 23.52
RadNet (RDNT) United States $4.431B 98.13
LifeStance Health (LFST) United States $3.057B 0.00
Amedisys (AMED) United States $3.010B 21.42
Addus HomeCare (ADUS) United States $2.427B 28.48
Astrana Health (ASTH) United States $1.978B 27.05
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.943B 38.14
Aveanna Healthcare Holdings (AVAH) United States $0.899B 0.00
Atai Life Sciences (ATAI) Germany $0.245B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00